Unlock Savings and Product Insights for Your Pharmacy!
Owen Mumford: Vital Updates for Medicare Part D Formulary
On January 1st, CVS Caremark revised their formulary, limiting insulin syringe and non-safety pen needle coverage to BD and Novo products. Owen Mumford has a workaround. Their Unifine SafeControl pen needles are approved at Rx submission, with a profitability of around $25—far surpassing the on-formulary options. Check out our informative PDF to stay in the know and empower your members.